uniQure BV (QURE) PT Lowered to $66 at Cantor Fitzgerald, Following Clinical Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
Tweet
Share
E-mailGet Alerts QURE Hot Sheet
Price: $23.87 --0%
Rating Summary:
27 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Rating Summary:
27 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Join SI Premium – FREE
Cantor Fitzgerald analyst Kristen Kluska lowered the price target on uniQure BV (NASDAQ: QURE) to $66.00 (from $70.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- uniQure (QURE) Tops Q3 EPS by 4c
- Max Healthcare Institute Ltd (MAXHEALT:IN) PT Lowered to INR1,000 at Axis Capital Limited
- Gujarat Fluorochemicals Ltd (FLUOROCH:IN) PT Raised to INR5,100 at Axis Capital Limited
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Cantor FitzgeraldSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
